Anthraflavicacid

Anthraflavicacid

SCHEMBL29985684

O=C1c2ccc(O)cc2C(=O)c2ccc(O)cc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 10/20 1.00
ESR1 P03372 9/20 1.00
MAOA P21397 1/20 1.00
UGT1A1 P22309 1/20 1.00
MAOB P27338 1/20 1.00
TTR P02766 1/20 0.67
BCL2 P10415 3/20 0.58
MCL1 Q07820 3/20 0.58
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
MEN1 O00255 1/20 0.52
NPC1 O15118 1/20 0.52
ALDH1A1 P00352 1/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
RAB9A P51151 1/20 0.52
KMT2A Q03164 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2772476 1.00 ESR2 (1.00) ESR2ESR1MAOAUGT1A1MAOB
Anthraflavicacid SCHEMBL31105422 1.00 ESR2 (1.00) ESR2ESR1MAOAUGT1A1MAOB
Anthraflavicacid SCHEMBL124974 1.00 ESR2 (1.00) ESR2ESR1MAOAUGT1A1MAOB
Anthraflavicacid SCHEMBL28758924 0.97 ESR2 (0.95) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL25270871 0.95 ESR2 (0.90) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL29486239 0.94 ESR2 (0.90) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL539276 0.94 ESR2 (0.90) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL15676175 0.94 ESR2 (0.90) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL30410371 0.94 ESR2 (0.90) ESR2ESR1MAOAUGT1A1MAOB
SCHEMBL18130042 0.93 ESR2 (0.86) ESR2ESR1MAOAUGT1A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12532684-B2 Protective film substance for laser processing and method of processing workpiece DISCO CORPORATION (JP) 2026-01-20 US disclosed
CN-120064792-A Power electronic equipment radiation emission level evaluation method based on reverberation room 西北工业大学 2025-05-30 CN disclosed
CN-118048285-A Genetically engineered bacterium for stably producing L-methionine and construction method and application thereof 浙江工业大学 2024-05-17 CN disclosed
CN-117511832-A Genetically engineered bacterium for synthesizing protocatechuic acid, construction method and application 湖北大学 2024-02-06 CN disclosed
CN-113913451-B Construction method of pichia pastoris engineering bacteria for producing inositol 山东福洋生物科技股份有限公司 2023-05-26 CN disclosed
US-20220392805-A1 PROTECTIVE FILM SUBSTANCE FOR LASER PROCESSING AND METHOD OF PROCESSING WORKPIECE DISCO CORPORATION (JP) 2022-12-08 US disclosed
EP-3615683-B1 METHODS FOR LINKING POLYNUCLEOTIDES BROAD INST INC (US) 2022-10-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12532684-B2 Protective film substance for laser processing and method of processing workpiece LTA, LCP1, CFH ESR2 4034/4885ESR1 3622/4885MAOA 209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.